Silverfin false false 30/04/2026 01/05/2025 30/04/2026 Dr Sarah Louise Oliver 07/04/2021 Michael Willis 31/03/2023 23 July 2026 The principal activity of the company during the year was the provision of medical services. 13319207 2026-04-30 13319207 bus:Director1 2026-04-30 13319207 bus:Director2 2026-04-30 13319207 2025-04-30 13319207 core:CurrentFinancialInstruments 2026-04-30 13319207 core:CurrentFinancialInstruments 2025-04-30 13319207 core:ShareCapital 2026-04-30 13319207 core:ShareCapital 2025-04-30 13319207 core:RetainedEarningsAccumulatedLosses 2026-04-30 13319207 core:RetainedEarningsAccumulatedLosses 2025-04-30 13319207 core:LandBuildings 2025-04-30 13319207 core:OtherPropertyPlantEquipment 2025-04-30 13319207 core:LandBuildings 2026-04-30 13319207 core:OtherPropertyPlantEquipment 2026-04-30 13319207 bus:OrdinaryShareClass1 2026-04-30 13319207 2025-05-01 2026-04-30 13319207 bus:FilletedAccounts 2025-05-01 2026-04-30 13319207 bus:SmallEntities 2025-05-01 2026-04-30 13319207 bus:AuditExemptWithAccountantsReport 2025-05-01 2026-04-30 13319207 bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 13319207 bus:Director1 2025-05-01 2026-04-30 13319207 bus:Director2 2025-05-01 2026-04-30 13319207 core:LandBuildings core:TopRangeValue 2025-05-01 2026-04-30 13319207 core:OtherPropertyPlantEquipment 2025-05-01 2026-04-30 13319207 2024-05-01 2025-04-30 13319207 core:LandBuildings 2025-05-01 2026-04-30 13319207 bus:OrdinaryShareClass1 2025-05-01 2026-04-30 13319207 bus:OrdinaryShareClass1 2024-05-01 2025-04-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 13319207 (England and Wales)

DR SARAH OLIVER LIMITED

Unaudited Financial Statements
For the financial year ended 30 April 2026
Pages for filing with the registrar

DR SARAH OLIVER LIMITED

Unaudited Financial Statements

For the financial year ended 30 April 2026

Contents

DR SARAH OLIVER LIMITED

COMPANY INFORMATION

For the financial year ended 30 April 2026
DR SARAH OLIVER LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 30 April 2026
DIRECTORS Dr Sarah Louise Oliver
Michael Willis
SECRETARY Dr Sarah Louise Oliver
REGISTERED OFFICE Wellington House Aviator Court
Clifton Moor
York
YO30 4UZ
United Kingdom
COMPANY NUMBER 13319207 (England and Wales)
ACCOUNTANT Inglis Chartered Accountants
Wellington House
Aviator Court
York
YO30 4UZ
DR SARAH OLIVER LIMITED

BALANCE SHEET

As at 30 April 2026
DR SARAH OLIVER LIMITED

BALANCE SHEET (continued)

As at 30 April 2026
Note 2026 2025
£ £
Fixed assets
Tangible assets 3 29,446 37,567
29,446 37,567
Current assets
Cash at bank and in hand 4 12,781 9,281
12,781 9,281
Creditors: amounts falling due within one year 5 ( 42,077) ( 43,645)
Net current liabilities (29,296) (34,364)
Total assets less current liabilities 150 3,203
Net assets 150 3,203
Capital and reserves
Called-up share capital 6 10 10
Profit and loss account 140 3,193
Total shareholders' funds 150 3,203

For the financial year ending 30 April 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Dr Sarah Oliver Limited (registered number: 13319207) were approved and authorised for issue by the Board of Directors on 23 July 2026. They were signed on its behalf by:

Dr Sarah Louise Oliver
Director
DR SARAH OLIVER LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2026
DR SARAH OLIVER LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Dr Sarah Oliver Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Wellington House Aviator Court, Clifton Moor, York, YO30 4UZ, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings 10 years straight line
Plant and machinery etc. 0 - 25 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Land and buildings Plant and machinery etc. Total
£ £ £
Cost
At 01 May 2025 5,000 58,298 63,298
At 30 April 2026 5,000 58,298 63,298
Accumulated depreciation
At 01 May 2025 1,000 24,731 25,731
Charge for the financial year 500 7,621 8,121
At 30 April 2026 1,500 32,352 33,852
Net book value
At 30 April 2026 3,500 25,946 29,446
At 30 April 2025 4,000 33,567 37,567

4. Cash and cash equivalents

2026 2025
£ £
Cash at bank and in hand 12,781 9,281

5. Creditors: amounts falling due within one year

2026 2025
£ £
Taxation and social security 7,023 1,537
Obligations under finance leases and hire purchase contracts 34,465 39,420
Other creditors 589 2,688
42,077 43,645

6. Called-up share capital

2026 2025
£ £
Allotted, called-up and fully-paid
10 Ordinary shares of £ 1.00 each 10 10